News
A therapy for Parkinson’s disease that can be delivered by a 24-hour subcutaneous infusion pump has been recommended for use by the NHS and could be an option for hundreds of patients with the ...
2mon
GlobalData on MSNSupernus wins FDA approval for Parkinson’s pump on fourth tryThe wearable pump is designed to provide a continuous subcutaneous infusion of Supernus’ apomorphine (Apokyn). The drug is ...
The global healthcare industry continues to evolve at an extraordinary pace, driven by advancements in medical technology and the ever-growing demand for personalized treatment solutions. Among the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results